Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation.
Stone GW, Abraham WT, Lindenfeld J, Kar S, Grayburn PA, Lim DS, Mishell JM, Whisenant B, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Asch FM, Mack MJ; COAPT Investigators. Stone GW, et al. Among authors: kar s. N Engl J Med. 2023 Jun 1;388(22):2037-2048. doi: 10.1056/NEJMoa2300213. Epub 2023 Mar 5. N Engl J Med. 2023. PMID: 36876756 Clinical Trial.
Transcatheter edge-to-edge repair for secondary mitral regurgitation with third-generation devices in heart failure patients - results from the Global EXPAND Post-Market study.
Orban M, Rottbauer W, Williams M, Mahoney P, von Bardeleben RS, Price MJ, Grasso C, Lurz P, Zamorano JL, Asch FM, Maisano F, Kar S, Hausleiter J. Orban M, et al. Among authors: kar s. Eur J Heart Fail. 2023 Mar;25(3):411-421. doi: 10.1002/ejhf.2770. Epub 2023 Jan 16. Eur J Heart Fail. 2023. PMID: 36597850 Free article.
Expanding the Spectrum of TEER Suitability: Evidence From the EXPAND G4 Post Approval Study.
Rogers JH, Asch F, Sorajja P, Mahoney P, Price MJ, Maisano F, Denti P, Morse MA, Rinaldi M, Bedogni F, De Marco F, Rollefson W, Chehab B, Williams MR, Leurent G, Morikawa T, Asgar AW, Rodriguez E, von Bardeleben RS, Kar S. Rogers JH, et al. Among authors: kar s. JACC Cardiovasc Interv. 2023 Jun 26;16(12):1474-1485. doi: 10.1016/j.jcin.2023.05.014. JACC Cardiovasc Interv. 2023. PMID: 37380229 Free article.
1-Year Outcomes of Transcatheter Edge-to-Edge Repair in Anatomically Complex Degenerative Mitral Regurgitation Patients.
Smith RL, Lim DS, Gillam LD, Zahr F, Chadderdon S, Rassi AN, Makkar R, Goldman S, Rudolph V, Hermiller J, Kipperman RM, Dhoble A, Smalling R, Latib A, Kodali SK, Lazkani M, Choo J, Lurz P, O'Neill WW, Laham R, Rodés-Cabau J, Kar S, Schofer N, Whisenant B, Inglessis-Azuaje I, Baldus S, Kapadia S, Szerlip M, Kliger C, Boone R, Webb JG, Williams MR, von Bardeleben RS, Ruf TF, Guerrero M, Eleid M, McCabe JM, Davidson C, Hiesinger W, Kaneko T, Shah PB, Yadav P, Koulogiannis K, Marcoff L, Hausleiter J; CLASP IID Pivotal Trial Investigators. Smith RL, et al. Among authors: kar s. JACC Cardiovasc Interv. 2023 Dec 11;16(23):2820-2832. doi: 10.1016/j.jcin.2023.10.020. Epub 2023 Oct 24. JACC Cardiovasc Interv. 2023. PMID: 37905772
Regurgitant volume to LA volume ratio in patients with secondary MR: the COAPT trial.
Coisne A, Scotti A, Granada JF, Grayburn PA, Mack MJ, Cohen DJ, Kar S, Lim DS, Lindenfeld J, Bax J, Kotinkaduwa LN, Redfors B, Weissman NJ, Asch FM, Stone GW. Coisne A, et al. Among authors: kar s. Eur Heart J Cardiovasc Imaging. 2024 Apr 30;25(5):616-625. doi: 10.1093/ehjci/jead328. Eur Heart J Cardiovasc Imaging. 2024. PMID: 38060997 Clinical Trial.
Two-Year Outcomes With a Next-Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial.
Doshi SK, Kar S, Sadhu A, Horton R, Osorio J, Ellis C, Stone J Jr, Shah M, Dukkipati SR, Adler S, Nair DG, Kim J, Wazni O, Price MJ, Holmes DR Jr, Shipley R, Christen T, Allocco DJ, Reddy VY; PINNACLE FLX investigators [Link]. Doshi SK, et al. Among authors: kar s. J Am Heart Assoc. 2023 Feb 21;12(4):e026295. doi: 10.1161/JAHA.122.026295. Epub 2023 Feb 15. J Am Heart Assoc. 2023. PMID: 36789852 Free PMC article.
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation.
Kar S, Doshi SK, Alkhouli M, Camm AJ, Coylewright M, Gibson MC, Granger CB, Gurol ME, Huber K, Mansour M, Nair DG, Natale A, Pocock SJ, Reddy VR, Saliba W, Christen T, Allocco DJ, Ellenbogen KA, Leon MB. Kar S, et al. Am Heart J. 2023 Oct;264:123-132. doi: 10.1016/j.ahj.2023.05.022. Epub 2023 Jun 4. Am Heart J. 2023. PMID: 37279840 Free article. Clinical Trial.
2,495 results